Last reviewed · How we verify

T89 capsule — Competitive Intelligence Brief

T89 capsule (T89 capsule) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal/Traditional medicine derivative; cardiac metabolic agent. Area: Cardiovascular.

phase 3 Herbal/Traditional medicine derivative; cardiac metabolic agent Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

T89 capsule (T89 capsule) — Tasly Pharmaceuticals, Inc.. T89 is a traditional Chinese medicine-derived compound that improves myocardial energy metabolism and enhances cardiac function through multiple pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
T89 capsule TARGET T89 capsule Tasly Pharmaceuticals, Inc. phase 3 Herbal/Traditional medicine derivative; cardiac metabolic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal/Traditional medicine derivative; cardiac metabolic agent class)

  1. Tasly Pharmaceuticals, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). T89 capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/t89-capsule. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: